| # | Drug | Count |
|---|---|---|
| 0 | OLANZAPINE | 1237 |
| 1 | OLANZAPINE PAMOATE | 1081 |
| 2 | RISPERIDONE | 741 |
| 3 | QUETIAPINE | 718 |
| 4 | ARIPIPRAZOLE | 606 |
| 5 | CLOZAPINE | 515 |
| 6 | LURASIDONE HYDROCHLORIDE | 449 |
| 7 | QUETIAPINE FUMARATE | 447 |
| 8 | ARIPIPRAZOLE ORAL | 426 |
| 9 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 426 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZIPRASIDONE HCL | 340 | 0.1278 |
| 1 | ASENAPINE MALEATE | 416 | 0.0480 |
| 2 | ZIPRASIDONE | 150 | 0.0416 |
| 3 | OLANZAPINE PAMOATE | 1081 | 0.0265 |
| 4 | LURASIDONE HYDROCHLORIDE | 449 | 0.0214 |
| 5 | OLANZAPINE | 1237 | 0.0177 |
| 6 | RISPERIDONE | 741 | 0.0098 |
| 7 | ZIPRASIDONE MESYLATE | 132 | 0.0093 |
| 8 | PALIPERIDONE PALMITATE | 233 | 0.0071 |
| 9 | ARIPIPRAZOLE | 606 | 0.0049 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 1004 |
| 1 | Corticosteroid [EPC] | 477 |
| 2 | Benzodiazepine [EPC] | 344 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 305 |
| 4 | Mood Stabilizer [EPC] | 171 |
| 5 | Alkylating Drug [EPC] | 170 |
| 6 | Insulin Analog [EPC] | 167 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 163 |
| 8 | Platinum-based Drug [EPC] | 159 |
| 9 | Loop Diuretic [EPC] | 147 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 28 | 0.0371 |
| 1 | Medium-chain Triglyceride [EPC] | 20 | 0.0361 |
| 2 | Leptin Analog [EPC] | 8 | 0.0063 |
| 3 | Carnitine Analog [EPC] | 19 | 0.0052 |
| 4 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 4 | 0.0048 |
| 5 | Methylating Agent [EPC] | 3 | 0.0029 |
| 6 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 3 | 0.0028 |
| 7 | Typical Antipsychotic [EPC] | 65 | 0.0026 |
| 8 | Lymphocyte Growth Factor [EPC] | 3 | 0.0024 |
| 9 | Atypical Antipsychotic [EPC] | 1004 | 0.0022 |